Article Text

Download PDFPDF
Sustained remission after infliximab in a child with vasculitis refractory to conventional immunosuppressives including interferon-α
  1. C Evereklioglu1,
  2. M Borlu2
  1. 1
    Department of Ophthalmology, Division of Uvea-Behçet Unit, Erciyes University Medical Faculty, Kayseri, Turkey
  2. 2
    Department Dermatology, Erciyes University Medical Faculty, Kayseri, Turkey
  1. Dr C Evereklioglu, Sivas Cad Cebeci Apt A-Blok 175/15, TR-38020, Kayseri, Turkey; evereklioglu{at}hotmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We report a 15-year-old Caucasian girl with longstanding sight-threatening bilateral uveitis who did not respond to intensive treatment with corticosteroids, azathioprine, ciclosporin and interferon over months with a progressive deterioration of vision in both eyes. She developed recurrent anterior chamber hypopyon formation, even when under the given medications. She had a rapid and dramatic response to treatment with infliximab, and long-term remission was obtained by continuous 24-month treatment with repeated infliximab infusions. This case highlights the role of anti-tumour necrosis factor …

View Full Text

Footnotes

  • Competing interests: None.

  • Patient consent: Obtained.